Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the bromo and fluoro substituents allow for selective cross-coupling reactions. Its structure supports the introduction of aromatic modifications that enhance metabolic stability and binding affinity in drug candidates. Commonly employed in the preparation of anti-inflammatory, antiviral, and central nervous system agents. Also utilized in agrochemical research for designing bioactive molecules with improved environmental stability.